1Hofmann SL. Retinoids-''differentiation agents'' for cancer treatment and prevention. Am J Med Sci,1992,304: 202-213.
2Funakoshi Y, Nakayama H, Uetsuka K, et al. Cellular proliferative and telomerase activity in canine mammary gland tumors. Vet Pathol, 2000, 37: 177-183.
2Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol, 2004,51 : 1-28.
3Leszczyniecka M, Roberts T, Dent P, et al. Differentiation therapy of human cancer: basic science and clinical applications. Pharmacal Ther, 2001,90 : 105-156.
4Li A,Zhu X, Brown B, et al. Gene expression networks underlying retinoic acid-induced differentiation of human retinoblastoma cells. Invest Ophthalmol Vis Sci, 2003,44:996-1007.
5Rodrigues MM, Wiggert B, Shields J, et al. Retinoblastoma. Immunohistochemistry and cell differentiation. Ophthalmology, 1987,94:378-387.
6Conway RM, Madigan MC, Billson FA, et al. Vincristine-and cisplatin-induced apoptosis in human retinoblastoma, potentiation by sodium butyrate. Eur J Cancer, 1998,34:1741-1748.
7Conway RM, Madigan MC, King NJ,et al. Human retinoblastoma : in vitro differentiation and immunoglobulin superfamily antigen modulation by retinoic acid. Cancer Immunol Immunother, 1997, 44:189-196.
8Fassina G, Aluigi MG, Gentleman S, et al. The cAMP analog 8-Cl-cAMP inhibits growth and induces differentiation and apoptosis in retinoblastoma ceils. Int J Cancer, 1997,72:1088-1094.
9Karasawa Y, Murakami A, Okisaka S. Apoptosis After Butyrate-Induced Differentiation in Retinoblastoma Cell Line Y-79. Jpn J Ophthalmol, 2000,44:601-609.
10Herman MM, Perentes E, Katsetos CD, et al. Neuroblastic differentiation potential of the human retinoblastoma cell lines Y-79 and WERI-Rbl maintained in an organ culture system. An immunohistochemical, electron microscopic, and biochemical study. Am J Pathol, 1989,134:115-132.
